Sign in

CIK 0001626878

  • Non-accelerated filer
  • Smaller reporting company

XBiotech Inc.

Sign in to watch
Ticker
XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 512-386-2900
Business address
5217 WINNEBAGO LANE, AUSTIN, TX, 78744
Open-market buys, last 90 days
$854,660
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$854,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SIMARD JOHN +$855K Director 2 filings
Date Insider Transaction Shares Price Value Owned after
2026-11-03 SIMARD JOHN Director Purchase +70,000 $2.05 $143K 4,261,690
2026-10-26 Simard Jan-Paul Co-Chief Executive Officer Grant or award · Stock Option +2,000,000 2,000,000
2026-10-26 SIMARD JOHN Director Purchase +368,524 $1.93 $711K 4,191,690
2025-10-01 Rademaker Craig Evan Director Grant or award · Director Stock Option +92,104 92,104
2025-10-01 Soffer David Spencer Director Grant or award · Director Stock Option +51,000 51,000
2025-10-01 Kuendig Thomas Martin Director Grant or award · Director Stock Option +79,115 79,115
2025-10-01 Troy Tevi David Director Grant or award · Director Stock Option +56,000 56,000
2025-03-17 SIMARD JOHN Chief Executive Officer Grant or award · Stock Option +1,026,228 1,896,609
2025-01-31 SIMARD JOHN Chief Executive Officer Other disposition · Convertible Loan Agreement −2,470,355 $10,000,000.00 $24703.5B 870,381
2024-06-20 MCKENZIE W THORPE Director Grant or award · Director Stock Option +37,500 37,500
2024-06-20 Waldin Jan-Paul Director Grant or award · Director Stock Option +37,500 37,500
2024-06-20 MacAdam Donald H. Director Grant or award · Director Stock Option +37,500 37,500
2024-06-20 Libby Peter Director Grant or award · Director Stock Option +37,500 37,500
2024-01-03 SIMARD JOHN Chief Executive Officer Purchase · Convertible Loan Agreement +2,470,355 $10,000,000.00 $24703.5B 3,840,736
2023-06-23 Waldin Jan-Paul Director Grant or award · Director Stock Option +25,000 25,000
2023-06-23 Libby Peter Director Grant or award · Director Stock Option +25,000 25,000
2023-06-23 MacAdam Donald H. Director Grant or award · Director Stock Option +25,000 25,000
2023-06-23 MCKENZIE W THORPE Director Grant or award · Director Stock Option +25,000 25,000
2023-02-10 SHIVASWAMY SUSHMA Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2022-06-22 MacAdam Donald H. Director Grant or award · Stock Option +25,000 25,000

Page 1 of 14 · 273 trades